Abstract
RVOT stenting has gained popularity over the last decade. Conventional treatment of choice in children with cyanotic heart defect with decreased pulmonary blood flow has always been the systemic to pulmonary arterial shunt, but lately, many centres are opting for RVOT stenting as the first choice of palliation. It is associated with fewer post-procedural complications and helps in a more physiological growth of pulmonary arteries, which can significantly impact the definitive repair at later date. Normally, RVOT stenting is performed in the early newborn period but it is not unusual to be done at a later age because of varied reasons. Two-point fixation of the stent ensures its safety against embolization but sparing the valve and covering the infundibular area only protect the child from future trans annular patches, though removing the stent can sometimes be challenging at a later stage. RVOT stenting has now become a safer alternative in centres with early stage of cardiac programmes.